Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-874 Phase 3 in Moderate to Severe Chronic Plaque Psoriasis
NCT00570986Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Nov 2007
- Primary completion
- Jun 2009
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of briakinumab in plaque psoriasis, sponsored by AbbVie Inc.. Started Nov 2007; status: completed.
02
Drugs
briakinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00570986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00570986.